Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Study of Ophthalmologic Function in Patients Receiving Long-Term Linezolid
2006-002303-14Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of linezolid in bacterial disease, sponsored by Pfizer. Primary endpoint: Optic nerve toxicity. Started Oct 2008; status: terminated.
02
Drugs
linezolid
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2006-002303-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002303-14.